Plaintiffs seek partial judgment on AndroGel patent in US antitrust case
MLex Summary: Plaintiffs asked a US federal judge to rule that a patent obtained by AbbVie and Besins relating to AndroGel is “prior art” in a case accusing them of delaying...To view the full article, register now.
Already a subscriber? Click here to view full article